I totally agree that an Agilyx IPO with a strong valuation can only be good for JBI. Regardless of what you think of either company there is no downside to a strong IPO for either company.
Right or wrong serious investors are not going to naturally flock to an OTC company that is controlled by a single shareholder with a weak board. The SEC suit until settled is also not beneficial nor frankly are any of the current filings. A strong IPO though could move those that lack the natural tendency to invest in a company like JBI into actually doing an evaluation. Then it is up to JBI to prove the goods.
Market Data 
Markets 
AI
